Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone

Identifieur interne : 003127 ( Main/Exploration ); précédent : 003126; suivant : 003128

Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone

Auteurs : Christine Kubiak [France] ; Patrick Couvreur [France] ; Luc Manil [France] ; Bernard Clausse [France]

Source :

RBID : ISTEX:F6C086A572E37A465F4FBAAB19FD52F91BF826A3

English descriptors

Abstract

Abstract: The cytotoxicities of free cyanoacrylic nanoparticles, free Adriamycin, Adriamycin-loaded nanoparticles and a mixture of Adriamycin and nanoparticles are compared in cancer cell cultures. Increased cytotoxicity was observed in the sensitive (DC3F) subline when Adriamycin was in paniculate form rather than free. In the derived pleiotropic resistant subline (DC3F AD/AZA), sensitivity to Adriamycin was completely restored with the conjugate. Addition of verapamil or amiodarone allowed an enhancement of efficiency of tenfold for free Adriamycin and between two- and fourfold for its conjugate form. Vectorization by nanoparticles and pharmacological modulation of cell membrane can act in synergy to overcome the resistance to Adriamycin in vitro.

Url:
DOI: 10.1016/0142-9612(89)90062-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone</title>
<author>
<name sortKey="Kubiak, Christine" sort="Kubiak, Christine" uniqKey="Kubiak C" first="Christine" last="Kubiak">Christine Kubiak</name>
</author>
<author>
<name sortKey="Couvreur, Patrick" sort="Couvreur, Patrick" uniqKey="Couvreur P" first="Patrick" last="Couvreur">Patrick Couvreur</name>
</author>
<author>
<name sortKey="Manil, Luc" sort="Manil, Luc" uniqKey="Manil L" first="Luc" last="Manil">Luc Manil</name>
</author>
<author>
<name sortKey="Clausse, Bernard" sort="Clausse, Bernard" uniqKey="Clausse B" first="Bernard" last="Clausse">Bernard Clausse</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F6C086A572E37A465F4FBAAB19FD52F91BF826A3</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1016/0142-9612(89)90062-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-MK6NQN06-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001807</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001807</idno>
<idno type="wicri:Area/Istex/Curation">001807</idno>
<idno type="wicri:Area/Istex/Checkpoint">001E92</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001E92</idno>
<idno type="wicri:doubleKey">0142-9612:1989:Kubiak C:increased:eytotoxicity:of</idno>
<idno type="wicri:Area/Main/Merge">003196</idno>
<idno type="wicri:Area/Main/Curation">003127</idno>
<idno type="wicri:Area/Main/Exploration">003127</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone</title>
<author>
<name sortKey="Kubiak, Christine" sort="Kubiak, Christine" uniqKey="Kubiak C" first="Christine" last="Kubiak">Christine Kubiak</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Pharmacie Galénique et de Biopharmacie, UA CNRS 1218, Université de Paris-Sud, 92290 Chatenay-Malabry</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Chatenay-Malabry</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Couvreur, Patrick" sort="Couvreur, Patrick" uniqKey="Couvreur P" first="Patrick" last="Couvreur">Patrick Couvreur</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Pharmacie Galénique et de Biopharmacie, UA CNRS 1218, Université de Paris-Sud, 92290 Chatenay-Malabry</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Chatenay-Malabry</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Manil, Luc" sort="Manil, Luc" uniqKey="Manil L" first="Luc" last="Manil">Luc Manil</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de Biologie Clinique et Unité de Médecine Nucléaire, Institut Gustave Roussy, 94805 Villejuif Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Villejuif</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Clausse, Bernard" sort="Clausse, Bernard" uniqKey="Clausse B" first="Bernard" last="Clausse">Bernard Clausse</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité d'Immunologie Cellulaire, Institut Gustave Roussy, 94805 Villejuif Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Villejuif</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Biomaterials</title>
<title level="j" type="abbrev">JBMT</title>
<idno type="ISSN">0142-9612</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1989">1989</date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="553">553</biblScope>
<biblScope unit="page" to="556">556</biblScope>
</imprint>
<idno type="ISSN">0142-9612</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0142-9612</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Adriamycin</term>
<term>Amiodarone</term>
<term>Cell lines</term>
<term>Cell membrane modulators</term>
<term>Cytotoxicity</term>
<term>Dc3f</term>
<term>Different drugs</term>
<term>Ibca</term>
<term>Ihca</term>
<term>Nanoparticles</term>
<term>Potentiation</term>
<term>Resistant cells</term>
<term>Subline</term>
<term>Toxicity</term>
<term>Tumoural cells</term>
<term>Verapamil</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The cytotoxicities of free cyanoacrylic nanoparticles, free Adriamycin, Adriamycin-loaded nanoparticles and a mixture of Adriamycin and nanoparticles are compared in cancer cell cultures. Increased cytotoxicity was observed in the sensitive (DC3F) subline when Adriamycin was in paniculate form rather than free. In the derived pleiotropic resistant subline (DC3F AD/AZA), sensitivity to Adriamycin was completely restored with the conjugate. Addition of verapamil or amiodarone allowed an enhancement of efficiency of tenfold for free Adriamycin and between two- and fourfold for its conjugate form. Vectorization by nanoparticles and pharmacological modulation of cell membrane can act in synergy to overcome the resistance to Adriamycin in vitro.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Chatenay-Malabry</li>
<li>Villejuif</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Kubiak, Christine" sort="Kubiak, Christine" uniqKey="Kubiak C" first="Christine" last="Kubiak">Christine Kubiak</name>
</region>
<name sortKey="Clausse, Bernard" sort="Clausse, Bernard" uniqKey="Clausse B" first="Bernard" last="Clausse">Bernard Clausse</name>
<name sortKey="Couvreur, Patrick" sort="Couvreur, Patrick" uniqKey="Couvreur P" first="Patrick" last="Couvreur">Patrick Couvreur</name>
<name sortKey="Manil, Luc" sort="Manil, Luc" uniqKey="Manil L" first="Luc" last="Manil">Luc Manil</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003127 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003127 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F6C086A572E37A465F4FBAAB19FD52F91BF826A3
   |texte=   Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021